What are granulomatous diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Are Granulomatous Diseases?

Granulomatous diseases are a heterogeneous group of conditions characterized by the formation of granulomas—organized collections of immune cells (primarily macrophages, epithelioid histiocytes, and multinucleated giant cells)—that can be broadly categorized into infectious and noninfectious causes. 1, 2

Core Definition and Pathology

Granulomas represent the body's attempt to wall off and contain substances it perceives as foreign but cannot eliminate. Histologically, they consist of:

  • Central core: Aggregates of macrophages and multinucleated giant cells
  • Outer layer: Loosely organized lymphocytes (mostly T cells) with interposed dendritic cells
  • Occasional B lymphocyte collections surrounding the granuloma 1

The granulomatous response forms when the immune system cannot eliminate an offending agent, leading to chronic inflammation and organized immune cell aggregation 3.

Major Categories

Infectious Granulomatous Diseases

These occur when pathogens cannot be cleared by the immune system and include:

  • Mycobacterial infections: Tuberculosis, atypical mycobacteria
  • Fungal infections: Histoplasmosis, coccidioidomycosis, aspergillosis
  • Parasitic infections: Leishmaniasis
  • Bacterial infections: Cat-scratch disease, syphilis, leprosy, actinomycosis 1, 2, 4, 3

Noninfectious Granulomatous Diseases

A diverse group including:

  • Sarcoidosis: Multisystem disorder with noncaseating granulomas
  • Hypersensitivity pneumonitis: Reaction to environmental antigens
  • Vasculitides: Granulomatosis with polyangiitis, Churg-Strauss syndrome
  • Chronic granulomatous disease (CGD): Hereditary immune deficiency with impaired phagocyte function 5, 6
  • Cutaneous disorders: Granuloma annulare, necrobiosis lipoidica, necrobiotic xanthogranuloma 7, 8
  • Drug-induced: Reactions to immune checkpoint inhibitors, anti-TNF-α agents
  • Malignancy-associated: Sarcoid-like reactions to tumors 1, 7

Critical Distinguishing Features

Necrotizing vs. Non-necrotizing

This is the most important initial classification when evaluating granulomas 9:

  • Necrotizing granulomas: Strongly suggest infection (tuberculosis, fungi), though some sarcoidosis variants can show focal necrosis
  • Non-necrotizing granulomas: More typical of sarcoidosis, hypersensitivity pneumonitis, but infection must still be excluded 1, 9

Granuloma Morphology

Well-formed (compact) granulomas: Tightly organized collections of epithelioid histiocytes—favor sarcoidosis or chronic beryllium disease 1

Poorly-formed (loose) granulomas: Loose clusters of histiocytes and giant cells—more typical of hypersensitivity pneumonitis 10, 9

Organ System Involvement

Granulomatous diseases can affect virtually any organ:

  • Lungs: Most common site (sarcoidosis, hypersensitivity pneumonitis, infections) 2, 9
  • Lymph nodes: Bilateral hilar adenopathy classic for sarcoidosis 1
  • Skin: Various patterns from papules to nodules 7, 8
  • Eyes: Uveitis, optic neuritis 1
  • Liver and spleen: Hepatosplenomegaly 1
  • Head and neck: Sinonasal cavities, salivary glands, orbits 4
  • Gastrointestinal, urinary tracts 5

Critical Diagnostic Pitfall

The single most important principle: histopathologic features alone cannot definitively distinguish between different granulomatous diseases. 1 You must:

  1. Always perform microorganism stains and cultures to exclude infection
  2. Correlate with clinical presentation, imaging, and laboratory data
  3. Consider the distribution pattern (perilymphatic vs. bronchiolocentric vs. random)
  4. Evaluate for specific associated features (necrosis quality, surrounding inflammation, vascular involvement)

Differential Diagnosis Considerations

When encountering granulomas, systematically exclude:

  • Infections first: Perform acid-fast bacilli stains, fungal stains, and cultures 1, 9
  • Occupational exposures: Berylliosis (requires blood lymphocyte proliferation test) 1
  • Drug reactions: Recent medication history, especially immunomodulators 1
  • Malignancy: Sarcoid-like reactions in patients with known or suspected cancer 1
  • Other systemic diseases: IgG4-related disease (check serum IgG4 levels), vasculitides (ANCA antibodies), common variable immunodeficiency 1, 10

Clinical Significance

The broad differential diagnosis means that misdiagnosis can have serious consequences 2. Treating presumed sarcoidosis with immunosuppression when infection is actually present can be fatal. Conversely, missing a diagnosis of sarcoidosis with cardiac or neurologic involvement can lead to significant morbidity and mortality from untreated inflammation.

Some granulomatous disorders may herald underlying malignancy (granuloma annulare, reactive granulomatous dermatitis, necrobiotic xanthogranuloma), requiring systematic evaluation 7.

References

Guideline

diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2020

Research

Granulomatous lung disease: clinical aspects.

Expert review of respiratory medicine, 2020

Research

Histologic features of granulomatous skin diseases.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2016

Research

Granulomatous disease in the head and neck: developing a differential diagnosis.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2014

Research

Inflammatory Complications in Chronic Granulomatous Disease.

Journal of clinical medicine, 2024

Research

Granulomatous annular diseases.

Clinics in dermatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.